te Boekhorst Paul Francis Olivier

te Boekhorst Paul Francis Olivier is listed in filings as President and CEO at ImmuCell Corporation. This profile follows SEC Form 4 activity through Jun 22, 2026, including purchase activity. Recent filings connect the profile to ImmuCell Corporation (ICCC). The current snapshot covers public activity from Nov 12, 2025 to Jun 22, 2026. Reported amounts are shown as $76.0K to $18.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.